J2787 HCPCS Level II code: Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml
J2787 is the HCPCS code for “Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2787Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml
Short description: Riboflavin photrexa/viscous
HCPCS · United States
Medicare details
The indicators CMS publishes with J2787 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2019
Where J2787 sits
- 1J codesDrugs administered other than orally
- 2Active code J2787Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2787 mean?
J2787 is the HCPCS code for “Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2787?
CMS lists J2787’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2787
All J codesJ2780Injection, ranitidine hydrochloride, 25 mgJ2781Injection, pegcetacoplan, intravitreal, 1 mgJ2782Injection, avacincaptad pegol, 0.1 mgJ2783Injection, rasburicase, 0.5 mgJ2785Injection, regadenoson, 0.1 mgJ2786Injection, reslizumab, 1 mgJ2788Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)J2789Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 mlJ2790Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)J2791Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iuJ2792Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iuJ2793Injection, rilonacept, 1 mg